South China Morning Post · Hangzhou Diagens Biotechnology

Chinese company to use AI-powered chromosome testing to boost profits and fast track IVF

· By Julie Zhang
Story summary

China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million after Hong Kong listing

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.